Acute Pain Relief: Current Landscape and Novel Pathways
Acute pain is experienced by nearly everyone at some point during their lifetime and is the most common reason for individuals presenting to the emergency department in the United States. Limited therapeutic options for acute pain have led to suboptimal pain management, which can impact quality of life and increase healthcare costs. Opioids are a mainstay in acute pain management, but they carry significant risks like nonmedical use of opioids and opioid use disorder and overdose.
Effective non-opioid analgesics for pain management are essential for protecting patient safety. Current guidelines recommend a thorough understanding of the definitions and mechanisms of pain to help guide treatment. Novel and emerging selective sodium channel blockers offer an effective alternative for acute pain. This activity will incorporate patient cases for pharmacists to evaluate the current therapeutic landscape for pain management, identify risks of untreated pain and opioid use, review pain pathophysiology, and apply the latest clinical evidence on new and emerging pain agents to optimize patient care.
Thursday, Jan. 14
12 - 1 p.m. ET
Registration is required for the webinar.
Speakers

Todd Brothers, PharmD, BCCCP, BCPS Activity Chair
Clinical Associate Professor of Pharmacy Practice
University of Rhode Island-College of Pharmacy
Kingston, Rhode Island
Todd Brothers is a Clinical Associate Professor of Pharmacy Practice at the University of Rhode Island College of Pharmacy. A graduate of MCPHS–Boston, he is board certified in pharmacotherapy and critical care pharmacy and provides adult critical care and internal medicine consultation at Roger Williams Medical Center in Providence, Rhode Island. His teaching spans critical care, pain management, pharmacogenomics, cardiology, and renal and pulmonary diseases. His scholarship explores artificial intelligence, including machine learning and natural language processing, to optimize medication use, strengthen clinical decision-making, and improve patient safety and healthcare outcomes.

L. Diana Ardeljan, PharmD, BCPS
Opioid Stewardship Pharmacist
Dana-Farber Cancer Institute
Boston, Massachusetts
Diana Ardeljan, PharmD, BCPS, is the Opioid Stewardship Pharmacist at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Ardeljan earned her PharmD from the University of Toronto and completed a PGY1 at Howard County General Hospital and PGY2 in Pain Management and Palliative Care at The Johns Hopkins Hospital. She was previously a Pain and Palliative Care Pharmacy Specialist at the University of Maryland Medical Center. Dr. Ardeljan has served on ASHP’s Pain and Palliative Care Section Advisory Group for three years, including as vice chair, and currently chairs the Pain Management and Palliative Care Taskforce. Her work focuses on safe opioid prescribing and technology-enabled approaches to opioid safety.
Target Audience
This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, and ambulatory clinics who care for or are interested in the care of patients with acute pain as well as pharmacists who are involved in formulary decisions at their institution.
Learning Objectives
-
Analyze pain physiology and emerging treatment options, including how these therapies target the underlying mechanisms of pain.
-
Identify the potential patient safety risks associated with undertreated pain and from opioid analgesic use to inform patient-centered pain management decisions.
-
Compare current pain management therapies based on patient-specific factors, efficacy, adverse events, and precautions associated with different analgesic options.
Agenda
- 12 p.m. – Welcome and Introductions
Todd Brothers - 12:05 p.m. – Pain Physiology and Emerging Therapeutic Approaches
Todd Brothers - 12:15 p.m. – Patient Safety Considerations in Pain Management
Todd Brothers - 12:30 p.m. – Evaluating and Individualizing Pain Management Strategies
L. Diana Ardeljan - 12:50 p.m. – Faculty Discussion, Questions and Answers
All Faculty
![]() |
Provided by ASHP and ASHP Foundation.
Sponsored by Vertex Pharmaceuticals Inc. For questions and assistance to participate, contact us. |
